Views & Analysis Women in Science: AstraZeneca We speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and how the industry can encourage and support more women to purs
Oncology ESMO26: Taiho Oncology on improving the lives of patients wi... Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.